Arkolith/Insider Trading/GENB/Form 4

Silvers Jason

President & CFOGenerate Biomedicines, Inc. (GENB) · full profile →Form 4 · filed Mar 2, 2026
Net Buying
Open-Market Buys
$32K
Open-Market Sells
$0
Net Open-Market Flow
$32K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Buy(P)1K$16.00$16K1K
Mar 2, 2026Buy(P)500$16.00$8K500
Mar 2, 2026Buy(P)500$16.00$8K500

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)274K—$0274K
Feb 26, 2026Grant(A)296K—$0296K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-085898) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML